Low dose oral administration of cytokines for treatment of allergic asthma

Pulmonary Pharmacology and Therapeutics

Volumn 22, Issue 6, 2009, Pages 497-510

  Gariboldi, Silvia ^a   Palazzo, Marco ^a   Zanobbio, Laura ^a   Dusio, Giuseppina F ^a   Mauro, Valentina ^a   Solimene, Umberto ^a   Cardani, Diego ^a   Mantovani, Martina ^a   Rumio, Cristiano ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Allergy; Cytokines; IFN ; IL 12; Lung; Mouse; Th1 Th2 Cells

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 5; RECOMBINANT INTERLEUKIN 12;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENTIATION; LOW DRUG DOSE; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PEANUT ALLERGY; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGENS, CD11C; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERFERON-GAMMA; INTERLEUKIN-12; LUNG; MALE; MICE; RECOMBINANT PROTEINS; RESPIRATORY HYPERSENSITIVITY; SOLUTIONS; SPLEEN; TH1 CELLS; TH2 CELLS;

EID: 71249155233     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2009.05.002     Document Type: Article

References (45)

1. Holgate S.T., and Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol 8 3 (2008) 218-230 10.1038/nri2262
2. Kaiko G.E., Horvat J.C., Beagley K.W., and Hansbro P.M. Immunological decision-making: how does the immune system decide to mount a helper T-cell response?. Immunology 123 3 (2008) 326-338 10.1111/j.1365-2567.2007.02719
3. Lafaille J.J. The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev 9 2 (1998) 139-151 10.1016/S1359-6101(98)00009-4
4. Seder R.A., and Paul W.E. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 12 (1994) 635-673
5. Mosmann T.R., and Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7 (1989) 145-173 10.1146/annurev.iy.07.040189.001045
6. Coffman R.L., Varkila K., Scott P., and Chatelain R. Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol Rev 123 (1991) 189-207
7. Marinaro M., Boyaka P.N., Jackson R.J., Finkelman F.D., Kiyono H., Jirillo E., et al. Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin. J Immunol 162 1 (1999) 114-121
8. Marinaro M., Boyaka P.N., Finkelman F.D., Kijono H., Jackson R.J., Jirillo E., et al. Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. $2.00. J Exp Med 185 3 (1997) 415-427 doi:0022-1007/97/02/415/14
9. Lee S.Y., Huang C.K., Zhang T.F., Schofield B.H., Burks A.W., Bannon G.A., et al. Oral administration of IL-12 suppresses anaphylactic reactions in a murine model of peanut hypersensitivity. Clin Immunol 101 2 (2001) 220-228 10.1006/clim.2001.5122
10. Vial T., and Descotes J. Immune-mediated side-effects of cytokines in humans. Toxicology 105 1 (1995) 31-57 10.1016/0300-483X(95)03124-X
11. Cummins J.M., Krakowka G.S., and Thompson C.G. Systemic effect of interferons after oral administration in animals and humans. Am J Vet Res 66 1 (2005) 164-176
12. Brod S.A., and Khan M. Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis. J Autoimmun 9 1 (1996) 11-20 10.1006/jaut.1996.0003
13. Avvakumov E.G., Chizhevskaya S.V., Stoyanov E.S., Povetkina M.V., Chekmarev A.M., Shafirov V.L., et al. Influence of the nature of components in mechanically activated mixture of zirconium and silicon oxides on solid-phase synthesis of zircon. Russ J Appl Chem+ 72 9 (1999) 1498-1503
14. Zec S., and Boskovic S. Cerium silicates formation from mechanically activated oxide mixtures. J Mater Sci 39 (2004) 5283-5286
15. Nakanishi A., Morita S., Iwashita H., Sagiya Y., Ashida Y., Shirafuji H., et al. Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc Natl Acad Sci U S A 98 9 (2001) 5175-5180 10.1073/pnas.081510898
16. Crosby J.R., Guha M., Tung D., Miller D.A., Bender B., Condon T.P., et al. Inhaled CD86 antisense oligonucleotide suppresses pulmonary inflammation and airway hyper-responsiveness in allergic mice. J Pharmacol Exp Ther 321 3 (2007) 938-946 doi:0022-3565/07/3213-938-946. $20.00
17. Edwan J.H., Perry G., Talmadge J.E., and Agrawal D.K. Flt-3 ligand reverses late allergic response and airway hyper-responsiveness in a mouse model of allergic inflammation. J Immunol 172 8 (2004) 5016-5023
18. Wiley R.E., Cwiartka M., Alvarez D., Mackenzie D.C., Johnson J.R., Goncharova S., et al. Transient corticosteroid treatment permanently amplifies the Th2 response in a murine model of asthma. J Immunol 172 8 (2004) 4995-5005
19. Manetti R., Parronchi P., Giudizi M.G., Piccinni M.P., Maggi E., Trinchieri G., et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177 (1993) 1199-1204 doi:0022-1007/93/04/1199/06. $2.00
20. Jagels M.A., Daffern P.J., Zuraw B.L., and Hugli T.E. Mechanisms and regulation of polymorphonuclear leukocyte and eosinophil adherence to human airway epithelial cells. Am J Respir Cell Mol Biol 21 3 (1999) 418-427
21. Monteleone G., Trapasso F., Parrello T., Biancone L., Stella A., Iuliano R., et al. Bioactive IL-18 expression is up-regulated in Crohn's disease. J Immunol 163 1 (1999) 143-147
22. Rollwagen F.M., and Baqar S. Oral cytokine administration. Immunol Today 17 12 (1996) 548-550 10.1016/S0167-5699(96)30065-0
23. Mosmann T.R., and Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17 3 (1996) 138-146 10.1016/0167-5699(96)80606-2
24. Abbas A.K., Murphy K.M., and Sher A. Functional diversity of helper T lymphocytes. Nature 383 6603 (1996) 787-793 10.1038/383787a0
25. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13 (1995) 251-276 10.1146/annurev.iy.13.040195.001343
26. Paul W.E., and Seder R.A. Lymphocyte responses and cytokines. Cell 76 2 (1994) 241-251 10.1016/0092-8674(94)90332-8
27. Hsieh C.S., Macatonia S.E., Tripp C.S., Wolf S.F., O'Garra A., and Murphy K.M. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260 5107 (1993) 547-549 10.1126/science.8097338
28. Nabors G.S., Afonso L.C., Farrell J.P., and Scott P. Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam. Proc Natl Acad Sci U S A 92 8 (1995) 3142-3146
29. Sypek J.P., Chung C.L., Mayor S.E., Subramanyam J.M., Goldman S.J., Sieburth D.S., et al. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 177 6 (1993) 1797-1802 doi:0022-1007/93/06/1797/06. $2.00
30. Wynn T.A., Cheever A.W., Jankovic D., Poindexter R.W., Caspar P., Lewis F.A., et al. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376 6541 (1995) 594-596 10.1038/376594a0
31. Chan S.H., Perussia B., Gupta J.W., Kobayashi M., Pospísil M., Young H.A., et al. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 173 4 (1991) 869-879 doi:0022-1007/91/04/0869/11. $2.00
32. Seder R.A., Gazzinelli R., Sher A., and Paul W.E. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci U S A 90 21 (1993) 10188-10192
33. Wynn T.A., Eltoum I., Oswald I.P., Cheever A.W., and Sher A. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med 179 5 (1994) 1551-1561
34. Stevenson M.M., Tam M.F., Wolf S.F., and Sher A. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. J Immunol 155 5 (1995) 2545-2556
35. Zhou P., Sieve M.C., Bennett J., Kwon-Chung K.J., Tewari R.P., Gazzinelli R.T., et al. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma. J Immunol 155 2 (1995) 785-795
36. Wynn T.A., Jankovic D., Hieny S., Zioncheck K., Jardieu P., Cheever A.W., et al. IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-gamma. J Immunol 154 8 (1995) 3999-4009
37. Ma X., Chow J.M., Gri G., Carra G., Gerosa F., Wolf S.F., et al. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med 183 1 (1996) 147-157 doi:0022-1007/96/01/147/11. $2.00
38. Murphy K.M., Ouyang W., Farrar J.D., Yang J., Ranganath S., Asnagli H., et al. Signaling and transcription in T helper development. Annu Rev Immunol 18 (2000) 451-494 10.1146/annurev.immunol.18.1.451
39. Li X.M., Chopra R.K., Chou T.Y., Schofield B.H., Wills-Karp M., and Huang S.K. Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice. J Immunol 157 8 (1996) 3216-3219
40. Lack G., Bradley K.L., Hamelmann E., Renz H., Loader J., Leung D.Y., et al. Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J Immunol 157 4 (1996) 1432-1439
41. Benjaponpitak S., Oro A., Maguire P., Marinkovich V., DeKruyff R.H., and Umetsu D.T. The kinetics of change in cytokine production by CD4 T cells during conventional allergen immunotherapy. J Allergy Clin Immunol 103 3 Pt 1 (1999) 468-475
42. Tompkins W.A. Immunomodulation and therapeutic effects of the oral use of interferon-alpha: mechanism of action. J Interferon Cytokine Res 19 8 (1999) 817-828 10.1089/107999099313325
43. Moore B.R., Krakowka S., Cummins J.M., and Robertson J.T. Changes in airway inflammatory cell populations in standardbred racehorses after interferon-alpha administration. Vet Immunol Immunopathol 49 4 (1996) 347-358 10.1016/0165-2427(95)05480-4
44. Romagnani S. Regulation of the T cell response. Clin Exp Allergy 36 11 (2006) 1357-1366 10.1111/j.1365-2222.2006.02606.x
45. Okazawa A., Kanai T., Watanabe M., Yamazaki M., Inoue N., Ikeda M., et al. Th1-mediated intestinal inflammation in Crohn's disease may be induced by activation of lamina propria lymphocytes through synergistic stimulation of interleukin-12 and interleukin-18 without T cell receptor engagement. Am J Gastroenterol 97 12 (2002) 3108-3117